Trials / Completed
CompletedNCT03320824
New Dermal Filler for Lip Augmentation
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane Kysse Versus a Control in the Augmentation of Soft Tissue Fullness of the Lip
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 273 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | New Dermal Filler | hyaluronic acid |
| DEVICE | Device: FDA Approved Dermal Filler | hyaluronic acid |
Timeline
- Start date
- 2017-11-13
- Primary completion
- 2018-06-28
- Completion
- 2019-04-23
- First posted
- 2017-10-25
- Last updated
- 2022-08-26
- Results posted
- 2020-06-18
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03320824. Inclusion in this directory is not an endorsement.